VTCN1 and ovarian carcinoma: In ovarian cancer patients, >70% of freshly isolated tumor macrophages expressed B7-H4 and in vitro B7-H4+ macrophages significantly decrease T cell proliferation and T cell activation upon TAA recognition [37].